Medical implants with a combination of compounds
OwnerWilliam L. Hunterinventor
Life of this patent
Estimating the term…
Abstract
Implants are associated with a combination of paclitaxel or derivatives and dipyridamole or derivatives in order to inhibit fibrosis that may otherwise occur when the implant is placed within an animal. Exemplary implants include intravascular implants (e.g., coronary and peripheral vascular stents, catheters, balloons), non-vascular stents, pumps and sensors, vascular grafts, perivascular devices, implants for hemodialysis access, vena cava filters, implants for providing an anastomotic connection, electrical devices, intraocular implants, and soft tissue implants and fillers.
Claims21
A device comprising a medical device, paclitaxel and dipyridamole, wherein paclitaxel is present in an amount ranging from about 0.01 to about 1.0 μg/mm2 and dipyridamole is present in an amount ranging from about 0.05 to about 50 μg/mm2 of medical device surface area.
A device comprising a medical device, paclitaxel and dipyridamole, wherein paclitaxel is present in an amount ranging from about 0.01 to about 1.0 μg/mm2 and dipyridamole is present in an amount ranging from about 0.01 to about 1.0 μg/mm2 of medical device surface area.
A composition comprising paclitaxel and dipyridamole, wherein the weight ratio of dipyridamole to paclitaxel exceeds 0.06 to 1.0.
Dependencies are inferred from the claim text.